This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van der Meer, M. Articles by Schoemaker, J. Search for Related Content PubMed PubMed Citation Articles by van der Meer, M. Articles by Schoemaker, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHORIONIC GONADOTROPIN ESTRADIOL

Cohort Size Rather Than Follicle-Stimulating Hormone Threshold Level Determines Ovarian Sensitivity in Polycystic Ovary Syndrome¹

Research Institute of Endocrinology, Reproduction and Metabolism, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, University Hospital Vrije Universiteit, 1007MB Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: Maartje van der Meer, Research Institute of Endocrinology, Reproduction and Metabolism, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, University Hospital Vrije Universiteit, P.O. Box 7057, 1007MB Amsterdam, The Netherlands.

The aim of the presented study was to compare FSH threshold levels and ovarian response to stimulation with one of two standard increments of exogenous FSH above the threshold in patients with polycystic ovary syndrome (PCOS) (n = 12) and eumenorrheic women (n = 11). The individual FSH threshold was determined by treatment according to a low-dose, step-up protocol with urinary FSH (Metrodin; Ares Serono, Geneva, Switzerland). In a subsequent treatment cycle, six PCOS patients and six eumenorrheic women were randomly assigned to double-blind treatment with the threshold dose plus 1/2 ampoule; the other six PCOS patients and five eumenorrheic women were treated with 1 ampoule above the threshold dose. Determination of threshold levels showed no significant differences in median and range between PCOS patients and eumenorrheic women. The number of follicles on the day of human chorionic gonadotropin administration showed no significant correlation with the increase in FSH level above the threshold level. Irrespective of the dose given, the number of follicles in the PCOS group was significantly higher than in eumenorrheic women. The higher sensitivity for gonadotropin stimulation in patients with PCOS compared with women with regular menstrual cycles therefore appears not to be dependent on differences in FSH threshold level, but rather on the larger size of the FSH sensitive cohort of small antral follicles.

This article has been cited by other articles:

				R. Azziz Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 781 - 785. [Abstract] [Full Text] [PDF]

				S. Jonard and D. Dewailly The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest Hum. Reprod. Update, March 1, 2004; 10(2): 107 - 117. [Abstract] [Full Text] [PDF]

				A. J. Zeleznik, L. Little-Ihrig, and S. Ramasawamy Administration of Dihydrotestosterone to Rhesus Monkeys Inhibits Gonadotropin-Stimulated Ovarian Steroidogenesis J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 860 - 866. [Abstract] [Full Text] [PDF]

				E.J.P. van Santbrink and B.C.J.M. Fauser Is there a future for ovulation induction in the current era of assisted reproduction? Hum. Reprod., December 1, 2003; 18(12): 2499 - 2502. [Abstract] [Full Text] [PDF]

				J. Kwee, M.W. Elting, R. Schats, P.D. Bezemer, C.B. Lambalk, and J. Schoemaker Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study Hum. Reprod., July 1, 2003; 18(7): 1422 - 1427. [Abstract] [Full Text] [PDF]

				M. S. Coffler, K. Patel, M. H. Dahan, P. J. Malcom, T. Kawashima, R. Deutsch, and R. J. Chang Evidence for Abnormal Granulosa Cell Responsiveness to Follicle-Stimulating Hormone in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1742 - 1747. [Abstract] [Full Text] [PDF]

				M. W. Elting, J. Kwee, R. Schats, L. T. M. Rekers-Mombarg, and J. Schoemaker The Rise of Estradiol and Inhibin B after Acute Stimulation with Follicle-Stimulating Hormone Predict the Follicle Cohort Size in Women with Polycystic Ovary Syndrome, Regularly Menstruating Women with Polycystic Ovaries, and Regularly Menstruating Women with Normal Ovaries J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1589 - 1595. [Abstract] [Full Text]

				S.D. Harlow, D.D. Baird, C.R. Weinberg, and A.J. Wilcox Urinary oestrogen patterns in long follicular phases Hum. Reprod., January 1, 2000; 15(1): 11 - 16. [Abstract] [Full Text] [PDF]

				M. W. Elting, T. J.M. Korsen, L. T.M. Rekers-Mombarg, and J. Schoemaker Women with polycystic ovary syndrome gain regular menstrual cycles when ageing Hum. Reprod., January 1, 2000; 15(1): 24 - 28. [Abstract] [Full Text] [PDF]

				S. Weil, K. Vendola, J. Zhou, and C. A. Bondy Androgen and Follicle-Stimulating Hormone Interactions in Primate Ovarian Follicle Development J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2951 - 2956. [Abstract] [Full Text]

				S. J. Weil, K. Vendola, J. Zhou, O. O. Adesanya, J. Wang, J. Okafor, and C. A. Bondy Androgen Receptor Gene Expression in the Primate Ovary: Cellular Localization, Regulation, and Functional Correlations J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2479 - 2485. [Abstract] [Full Text]